- The Washington Times - Wednesday, July 5, 2006

NEW YORK (AP) — Stomach cancer patients live longer if they get chemotherapy before and after surgery, British researchers report.

Chemotherapy cut the risk of death by a quarter compared with surgery alone, according to the study published in today’s New England Journal of Medicine. It also shrank tumors and improved chances of survival without relapse.

The results provide a new option for the treatment of operable stomach cancer, Dr. John S. Macdonald, of St. Vincent’s Comprehensive Cancer Center in New York, wrote in an accompanying editorial.

Surgery is the standard treatment for stomach cancer, with all or part of the stomach removed. There’s a good chance of a cure if the cancer is caught early, but stomach cancer usually isn’t detected until it is more advanced. Chemotherapy after surgery hasn’t proved very beneficial in killing any lingering cancer cells.

In the United States, about 22,300 new cases will be diagnosed this year and about 11,400 people will die of the disease.

In a study of 503 patients conducted primarily in Britain, doctors tried giving chemotherapy both before and after surgery to those with operable stomach cancer or cancer of the esophagus.

After five years, 36 percent of those who got chemotherapy were alive compared with 23 percent of those who had only surgery.

The research was led by Dr. David Cunningham of Royal Marsden Hospital in Sutton and supported by Britain’s Medical Research Council, with the cost of one chemotherapy drug paid for by its manufacturer.

The researchers said side effects from the chemotherapy were similar to those reported by other stomach cancer patients. They noted that the chemotherapy combination used — epirubicin, cisplatin and fluorouracil — was developed in the 1980s and that newer drugs are now available.

The newer drugs will have to be tested in a similar study to see whether they are better than the older combination, Dr. Macdonald said.

Copyright © 2018 The Washington Times, LLC. Click here for reprint permission.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide